Axcella Health Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Axcella Health.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 23.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
Axcella Therapeutics drops 9% on $34.2M stock offering
Oct 13Axcella adds 20% as mid-stage trial indicates potential of NASH therapy
Sep 29Axcella Health GAAP EPS of -$0.40 misses by $0.02
Aug 12Axcella Health: Revisiting A Lottery Ticket
Apr 25Axcella Health EPS beats by $0.01
May 06Have Insiders Been Buying Axcella Health Inc. (NASDAQ:AXLA) Shares This Year?
Feb 19
Axcella decides not to expand enrollment in AXA4010-001 following cohort 1 readout
Jan 11Is Axcella Health Inc.'s (NASDAQ:AXLA) Shareholder Ownership Skewed Towards Insiders?
Dec 28
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Axcella Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2023 | N/A | -48 | -43 | -43 | N/A |
| 3/31/2023 | N/A | -66 | -58 | -58 | N/A |
| 12/31/2022 | N/A | -81 | -70 | -70 | N/A |
| 9/30/2022 | N/A | -76 | -68 | -68 | N/A |
| 6/30/2022 | N/A | -74 | -62 | -61 | N/A |
| 3/31/2022 | N/A | -68 | -57 | -57 | N/A |
| 12/31/2021 | N/A | -65 | -54 | -54 | N/A |
| 9/30/2021 | N/A | -62 | -51 | -51 | N/A |
| 6/30/2021 | N/A | -59 | -50 | -49 | N/A |
| 3/31/2021 | N/A | -57 | -48 | -47 | N/A |
| 12/31/2020 | N/A | -57 | -50 | -50 | N/A |
| 9/30/2020 | N/A | -57 | -53 | -53 | N/A |
| 6/30/2020 | N/A | -62 | -55 | -55 | N/A |
| 3/31/2020 | N/A | -62 | -55 | -55 | N/A |
| 12/31/2019 | N/A | -59 | -51 | -51 | N/A |
| 9/30/2019 | N/A | -53 | -45 | -45 | N/A |
| 6/30/2019 | N/A | -45 | -41 | -40 | N/A |
| 3/31/2019 | N/A | -40 | -35 | -35 | N/A |
| 12/31/2018 | N/A | -36 | -31 | -31 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if AXLA's forecast earnings growth is above the savings rate (2.2%).
Earnings vs Market: Insufficient data to determine if AXLA's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if AXLA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if AXLA's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if AXLA's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AXLA's Return on Equity is forecast to be high in 3 years time